unknown
Stage
3
Investors
About
ADARx Pharmaceuticals is a clinical-stage biotechnology company developing RNA-based therapeutics using proprietary RNA science and targeted delivery platforms. Its pipeline includes multiple candidates (e.g., ADX-038/Agazisiran and others) targeting renal, hematologic, metabolic and neurodegenerative diseases.
Explore ADARx Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.